CIK 0001533040
- Non-accelerated filer
- Smaller reporting company
Phio Pharmaceuticals Corp.
Sign in to watch- Ticker
- PHIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453215903
- Phone
- +1 508-767-3861
- Business address
- 411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
- Former names
- RXi Pharmaceuticals Corp
- Open-market buys, last 90 days
- $86,928
- in 8 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$86,928. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-02-25 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −5,000 | $6.00 | $30K | 1,289,015 |
| 2014-02-25 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −5,000 | $6.55 | $33K | 1,284,015 |
| 2014-02-24 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −1,575 | $6.30 | $10K | 1,266,585 |
| 2014-02-21 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −5,641 | $4.75 | $27K | 1,288,736 |
| 2014-02-21 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −2,900 | $4.74 | $14K | 1,285,836 |
| 2014-02-21 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −2,100 | $4.71 | $10K | 1,283,736 |
| 2014-02-21 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −576 | $4.80 | $3K | 1,283,160 |
| 2014-02-21 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −5,000 | $5.15 | $26K | 1,278,160 |
| 2014-02-21 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −5,000 | $4.85 | $24K | 1,273,160 |
| 2014-02-21 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −5,000 | $5.00 | $25K | 1,268,160 |
| 2014-02-20 | Advanced RNA Technologies, LLC 10% owner | Other disposition | −1,200 | $4.70 | $6K | 1,294,377 |
| 2013-10-31 | CAUWENBERGH GEERT President & CEO | Purchase | +800 | $3.19 | $3K | 21,100 |
| 2013-10-30 | CAUWENBERGH GEERT President & CEO | Purchase | +200 | $3.09 | $618 | 20,300 |
| 2013-10-23 | CAUWENBERGH GEERT President & CEO | Purchase | +1,000 | $3.34 | $3K | 20,100 |
| 2013-10-22 | CAUWENBERGH GEERT President & CEO | Purchase | +300 | $3.43 | $1K | 19,100 |
| 2013-10-18 | CAUWENBERGH GEERT President & CEO | Purchase | +100 | $3.29 | $329 | 18,500 |
| 2013-10-18 | CAUWENBERGH GEERT President & CEO | Purchase | +100 | $3.38 | $338 | 18,600 |
| 2013-10-18 | CAUWENBERGH GEERT President & CEO | Purchase | +200 | $3.50 | $700 | 18,800 |
| 2013-10-16 | CAUWENBERGH GEERT President & CEO | Purchase | +100 | $3.53 | $353 | 18,400 |
| 2013-10-15 | CAUWENBERGH GEERT President & CEO | Purchase | +100 | $3.51 | $351 | 18,300 |
Page 15 of 22 · 421 trades